Published in Endocrinology on October 01, 1994
In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol (2005) 1.31
Membrane oestrogen receptors on rat pituitary tumour cells: immuno-identification and responses to oestradiol and xenoestrogens. Exp Physiol (1999) 1.22
Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol (1996) 1.11
PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J (1996) 1.02
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol (2010) 0.99
Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1. Mol Endocrinol (2009) 0.84
The GH/IGF-1 Axis and Heart Failure. Curr Cardiol Rev (2009) 0.84
Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues. Endocrinology (2012) 0.82
Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping. Endocrinology (2011) 0.82
Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system. Biochim Biophys Acta (2008) 0.80
Transcriptome analysis of food habit transition from carnivory to herbivory in a typical vertebrate herbivore, grass carp Ctenopharyngodon idella. BMC Genomics (2015) 0.77
Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes. Bone Res (2013) 0.77
Famine to feast--growth hormone and prolactin signal transducers. Endocrinology (1994) 0.75
Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev (1998) 3.82
Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev (1997) 3.12
IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol (1999) 2.69
Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med (1989) 2.45
An actin-binding site containing a conserved motif of charged amino acid residues is essential for the morphogenic effect of villin. Cell (1992) 2.01
Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell (1988) 2.00
Are younger classroom children disproportionately referred for childhood academic and behavior problems? J Consult Clin Psychol (1987) 1.99
Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology (1974) 1.81
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol (1999) 1.70
Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J (1991) 1.69
Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol (2001) 1.66
Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell (1989) 1.60
BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant (2012) 1.60
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology (1985) 1.58
Radioreceptor assay for prolactin and other lactogenic hormones. Science (1973) 1.56
Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest (2000) 1.54
Comparative transcriptional and phenotypic peripheral blood analysis of kidney recipients under cyclosporin A or sirolimus monotherapy. Am J Transplant (2010) 1.54
The prolactin/growth hormone receptor family. Endocr Rev (1991) 1.53
A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab (1996) 1.49
Sequence of human villin: a large duplicated domain homologous with other actin-severing proteins and a unique small carboxy-terminal domain related to villin specificity. J Cell Biol (1988) 1.49
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48
Readability of pediatric biomedical research informed consent forms. Pediatrics (1990) 1.43
Biosynthesis and intracellular sorting of growth hormone-viral envelope glycoprotein hybrids. J Cell Biol (1985) 1.42
Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics (2011) 1.40
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology (1994) 1.40
Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A (1991) 1.40
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39
Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev (1996) 1.38
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem (1992) 1.35
A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture. EMBO J (1986) 1.35
Disproportionate referrals for child academic/behavior problems: replication and extension. J Consult Clin Psychol (1990) 1.35
Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy. Endocrinology (1974) 1.35
Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. Cancer Res (1987) 1.32
Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab (1998) 1.31
The utility of the Kohlman Evaluation of Living Skills test is associated with substantiated cases of elder self-neglect. J Am Acad Nurse Pract (2007) 1.29
Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Lett (1991) 1.28
Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol (1992) 1.27
Null mutation of the prolactin receptor gene produces a defect in maternal behavior. Endocrinology (1998) 1.27
Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland. Proc Natl Acad Sci U S A (1989) 1.26
Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1993) 1.25
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest (2000) 1.24
Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia (1997) 1.23
Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J Biol Chem (1999) 1.22
Evolution of prolactin receptors in rabbit mammary gland during pregnancy and lactation. Endocrinology (1977) 1.21
Induction of a lactogenic receptor in rat liver: influence of estrogen and the pituitary. Proc Natl Acad Sci U S A (1974) 1.18
Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem (1995) 1.18
Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem (1994) 1.17
Expression of two forms of prolactin receptor in rat ovary and liver. Mol Endocrinol (1990) 1.17
Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab (1988) 1.16
Prolactin receptors in rat liver: possible induction by prolactin. Science (1975) 1.15
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci U S A (1994) 1.14
Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant (2013) 1.14
The growth hormone/prolactin receptor family. Recent Prog Horm Res (1993) 1.11
Immune system development and function in prolactin receptor-deficient mice. J Immunol (1999) 1.10
Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats. J Neurosci (1984) 1.10
Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.09
Significant differences in charge times among currently available implantable cardioverter defibrillators. Pacing Clin Electrophysiol (1999) 1.08
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab (1997) 1.07
Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am J Physiol (1995) 1.06
Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab (2001) 1.06
Leptin binding activity changes with age: the link between leptin and puberty. J Clin Endocrinol Metab (1999) 1.06
A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J Biol Chem (1991) 1.05
Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett (1999) 1.05
Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology (2001) 1.04
Mutational analysis of the ligand-binding domain of the prolactin receptor. J Biol Chem (1991) 1.04
Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem (1994) 1.04
In vitro biosynthesis and membrane insertion of gamma-glutamyl transpeptidase. J Biol Chem (1984) 1.02
Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol Reprod (2000) 1.02
PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J (1996) 1.02
Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol (1993) 1.02
Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology (1999) 1.01
Ultrastructural localization of the progesterone receptor by an immunogold method: effect of hormone administration. J Cell Biol (1986) 1.01
Biosynthesis and processing of gamma-glutamyl transpeptidase in hepatoma tissue culture cells. J Biol Chem (1984) 1.01
Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development. J Clin Invest (1997) 1.01
Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol Endocrinol (1996) 1.00
A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol (1997) 0.99
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity. Clin Transplant (2000) 0.99
Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature (1984) 0.99
The prolactin receptor in the fetal rat: cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation. Endocrinology (1995) 0.99
Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis (1998) 0.98
A rapid method of epitope mapping. Application to the study of immunogenic domains and to the characterization of various forms of rabbit progesterone receptor. Eur J Biochem (1988) 0.98
The prolactin/growth hormone receptor family: structure/function relationships. J Mammary Gland Biol Neoplasia (1997) 0.98
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene (2000) 0.97
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab (1993) 0.96
Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG. J Biol Chem (1990) 0.96
Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab (1982) 0.96
The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol (1997) 0.96
Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice. Endocrinology (2001) 0.96
Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol (2006) 0.96
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin. Biochem Biophys Res Commun (1977) 0.95
Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase. Hepatology (1983) 0.95
Inhibition of nitric oxide synthase does not impair spatial learning. J Neurosci (1994) 0.95